Pharmaceutical composition for treating ulcerative colitis, its preparation method and use

Abstract

The invention discloses a pharmaceutical composition for treating ulcerative colitis, which is prepared from astragalus root and flavescent sophora root as the raw material. the invention also provides the method for preparation and use of the pharmaceutical composition.

Description

technical field The invention relates to a pharmaceutical composition for treating ulcerative colitis, specifically, a pharmaceutical composition prepared from Chinese medicinal materials, a preparation method and application thereof, and belongs to the field of traditional Chinese medicine. Background technique Ulcerative colitis is a primary, nonspecific chronic disease of the colon. Under colonoscopy, only the mucosa and submucosa of the colon can be seen, with erosions and superficial ulcers. At present, Western medicine mainly includes the following types of drugs for the treatment of ulcerative colitis: sulfonamides, antibiotics, metronidazole, hormone therapy, oral corticosteroids, topical administration, and immunosuppressants; the above-mentioned western medicines have passed long-term efficacy tests and clinical trials All proved to have reliable therapeutic effects, but most of them are highly toxic and have many side effects, such as: nausea and vomiting, heada...

AI Technical Summary

Problems solved by technology

Although it has been reported that the traditional Chinese medicinal materials Astragalus and Sophora flavescens are used simultaneously to treat other diseases, or used separately to treat ulcerative colitis, there is no relevant report on the combined use of the two raw materials to treat ulcerative colitis.

Images